FindTrial
Sign In

Study with methyl salicylate 30 g to evaluate the safety and effectiveness of methyl salicylate 30 g and 1 g benzocaine ointment as an adjunct in the treatment of knee osteoarthritis and musculoskeletal pain.

Phase III clinical trial, double-blind, randomized, controlled with methyl salicylate 30 g to evaluate the safety and effectiveness of methyl salicylate 30 g and 1 g benzocaine ointment as an adjunct in the treatment of knee osteoarthritis and musculoskeletal pain.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-036-13
Enrollment
40
Registered
2014-04-30
Start date
2013-07-25
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Combination 30 g methyl salicylate 1 g benzocaine ointment applied 5g (equivalent to a spoon) three times a day topical routes of administration. They selected 40 patients attending the center with m

Sponsors

LABORATORIOS FARMASUR S.A.C.,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years o With clinical diagnosis (contained in medical records) of: Knee pain and osteoarthritis product musculoskeletal pain or mechanical type (low back pain, neck pain, knee pain) They have given their informed consent.

Exclusion criteria

Exclusion criteria: Be excluded: Patients with any history of adverse reactions of components forming part of the treatment. Patients with lesions / wounds or conditions that impair the integrity of the skin in the areas where the product is applied. Women pregnant or breastfeeding are providing.

Countries

Peru

Contacts

Public ContactIvon Mendoza

LABORATORIOS FARMASUR S.A.C.

ivonmv@hotmail.com4444081, 995775999

Outcome results

None listed

Source: REPEC (via WHO ICTRP)